biote Corp. (BTMD)
1.07
-0.02
(-1.83%)
USD |
NASDAQ |
Oct 23, 16:00
1.06
-0.01
(-0.93%)
After-Hours: 20:00
biote Debt to Equity Ratio : -1.955 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.955 |
| March 31, 2026 | -1.933 |
| December 31, 2025 | -2.194 |
| September 30, 2025 | -2.019 |
| June 30, 2025 | -1.806 |
| March 31, 2025 | -1.993 |
| December 31, 2024 | -1.697 |
| September 30, 2024 | -0.9383 |
| June 30, 2024 | -0.8538 |
| March 31, 2024 | -3.216 |
| Date | Value |
|---|---|
| December 31, 2023 | -3.908 |
| September 30, 2023 | -2.870 |
| June 30, 2023 | -2.536 |
| March 31, 2023 | -2.452 |
| December 31, 2022 | -2.709 |
| September 30, 2022 | -2.492 |
| June 30, 2022 | -2.469 |
| March 31, 2022 | -0.4994 |
| December 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cannabis Strategic Ventures, Inc. | -0.8919 |
| Rafael Holdings, Inc. | 0.0081 |
| Concentra Group Holdings Parent, Inc. | 4.494 |
| Elite Health Systems, Inc. | 0.0074 |
| U.S. Stem Cell, Inc. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 101.70M |
| Total Liabilities (Quarterly) | 159.89M |
| Shareholders Equity (Quarterly) | -65.79M |
| Current Ratio | 1.430 |
| Net Debt Paydown Yield | 19.39% |